These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 4323223)
41. Inhibition of herpes simplex virus by synthetic double-stranded RNA (polyriboadenylic and polyribouridylic acids and polyriboinosinic and polyribocytidylic acids). Hamilton LD; Babcock VI; Southam CM Proc Natl Acad Sci U S A; 1969 Nov; 64(3):878-83. PubMed ID: 4313333 [TBL] [Abstract][Full Text] [Related]
43. [Test of an antiviral treatment in some cutaneo-mucosal diseases]. David V; Kuffer R Sem Ther; 1967 May; 43(5):305-7. PubMed ID: 4299985 [No Abstract] [Full Text] [Related]
45. [Virustatic drug therapy]. Pötsch F Ther Ggw; 1973 Apr; 112(4):536-7 passim. PubMed ID: 4725293 [No Abstract] [Full Text] [Related]
46. [Comparative evaluatio of the antiviral activity of the antibiotic rubomycin-complex and its components B and C]. Bliumberg NA; Kalamova NI Antibiotiki; 1970 Apr; 15(4):307-11. PubMed ID: 5489277 [No Abstract] [Full Text] [Related]
47. [Interferon, inducers of its formation -- interferonogens and prospects of their use in viral diseases of the eye (literature survey)]. Zeĭtlenok NA; Vil'ner LM; Kasparov AA Vestn Oftalmol; 1966; 79(6):80-3. PubMed ID: 4296552 [No Abstract] [Full Text] [Related]
48. Difference in interferon response and protection from ocular virus infection in rabbits and monkeys. Kaufman HE; Ellison ED; Centifanto YM Am J Ophthalmol; 1972 Jul; 74(1):89-92. PubMed ID: 4338613 [No Abstract] [Full Text] [Related]
50. Interaction between DEAE-dextran and nucleic acids. II. Effect on interferon production in vivo. Maes RF; Fernandes MV Arch Gesamte Virusforsch; 1970; 30(2):147-54. PubMed ID: 4318577 [No Abstract] [Full Text] [Related]
51. Current leads in antiviral chemotherapy. De Clercq E J Antimicrob Chemother; 1986 Apr; 17(4):399-402. PubMed ID: 3011723 [No Abstract] [Full Text] [Related]
52. Effectiveness of therapy with a multistranded synthetic polynucleotide complex against a murine sarcoma virus. Pearson JW; Turner W; Ebert PS; Chirigos MA Appl Microbiol; 1969 Sep; 18(3):474-8. PubMed ID: 5373679 [TBL] [Abstract][Full Text] [Related]
53. Antiviral drug development: the road less taken. Balfour HH Ann Pharmacother; 1996 Sep; 30(9):964-6. PubMed ID: 8876857 [No Abstract] [Full Text] [Related]
54. In vivo antiviral activity of polynucleotide mimics of strategic regions in viral RNA. Stebbing N; Grantham CA; Lindley IJ; Eaton MA; Carey NH Ann N Y Acad Sci; 1977 Mar; 284():682-96. PubMed ID: 280157 [No Abstract] [Full Text] [Related]
55. Antiviral activity and side effects of polyriboinosinic-cytidylic acid complexes as affected by molecular size. Morahan PS; Munson AE; Regelson W; Commerford SL; Hamilton LD Proc Natl Acad Sci U S A; 1972 Apr; 69(4):842-6. PubMed ID: 4337241 [TBL] [Abstract][Full Text] [Related]
57. Toxicity of poly I: poly C for rabbit eyes. Ostler HB; Oh JO; Dawson CR; Burt WL Nature; 1970 Oct; 228(5269):362-4. PubMed ID: 4319742 [No Abstract] [Full Text] [Related]
58. [Clinical experience with double stranded ribonucleic acid inducing interferon (author's translation)]. Borecký L; Doskocil J; Lackovic V; Buchvald J; Malý E; Gruntová Z; Obrucník M; Obrucníková E; Havránková M; Vrbovský L; H'radecná Z; Ebringer L; Hlavatý J; Hegyi E Cas Lek Cesk; 1977 Jun; 116(22):673-8. PubMed ID: 195731 [No Abstract] [Full Text] [Related]
59. Inhibition of spontaneous mammary carcinoma of mice by treatment with interferon and poly I:C. Came PE; Moore DH Proc Soc Exp Biol Med; 1971 May; 137(1):304-5. PubMed ID: 4325777 [No Abstract] [Full Text] [Related]
60. Clinical studies of an interferon inducer, polyriboinosinic-polyribocytidylic acid [poly (I)-poly (C)], in children. Guggenheim MA; Baron S J Infect Dis; 1977 Jul; 136(1):50-8. PubMed ID: 328786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]